Cognition Therapeutics CGTX
NASDAQ CGTX
$1.00 +0.04 (+4.10%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cognition Therapeutics (CGTX) Tax Provisions (2022)

Cognition Therapeutics (CGTX) posted quarterly Tax Provisions of -$125000.0 for Q2 2022, down 200.0% quarter-over-quarter from $125000.0 in Q1 2022.

Cognition Therapeutics (CGTX) Tax Provisions (2022) Analysis & Trends

Cognition Therapeutics (CGTX) has reported Tax Provisions for 1 consecutive years, with -$125000.0 the latest figure, recorded in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 59.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 15.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 75.45 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 13.31 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -90.33 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.90 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cognition Therapeutics 90.18 Mn 90.18 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 -125,000.00
Mar 31, 2022 125,000.00